KERX
Keryx Biopharmaceuticals Inc
KERX
KERX
Delisted
KERX was delisted on the 12th of December, 2018.
123 hedge funds and large institutions have $253M invested in Keryx Biopharmaceuticals Inc in 2018 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 32 increasing their positions, 42 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
123
Holders Change
-9
Holders Change %
-6.82%
% of All Funds
2.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
32
Reduced
42
Closed
22
Calls
$1.1M
Puts
$1.46M
Net Calls
-$355K
Net Calls Change
-$349K
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$3.47M |
| 2 |
BlackRock
New York
|
+$1.99M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.95M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.1M |
| 5 |
Citigroup
New York
|
+$729K |
Top Sellers
| 1 |
ACM
Abrams Capital Management
Boston,
Massachusetts
|
-$2.86M |
| 2 |
Morgan Stanley
New York
|
-$2.54M |
| 3 |
RA
Royce & Associates
New York
|
-$965K |
| 4 |
CEP
Chicago Equity Partners
Chicago,
Illinois
|
-$747K |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$573K |
